Press Releases for THRX

Press Releases
Theravance Announces New Employment Inducement Awards
Theravance Reports Second Quarter 2009 Financial Results
Theravance to Report Second Quarter 2009 Financial Results on July 23, 2009
Theravance Announces New Employment Inducement Awards
Theravance Announces New Employment Inducement Awards
Theravance to Present at Investor Conferences in June 2009
Theravance Announces New Employment Inducement Awards
Theravance to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
FDA Accepts for Review Theravance's Complete Response Submission for Telavancin for the Treatment of Complicated Skin and Skin Structure Infections
Theravance to Webcast 2009 Annual Meeting of Stockholders on April 24, 2009
Theravance to Report First Quarter 2009 Financial Results on April 22, 2009
Theravance Announces FDA Acceptance of Telavancin NDA for the Treatment of Hospital-Acquired Pneumonia
Theravance Announces New Employment Inducement Awards - PrimeZone
Theravance to Present at the Cowen and Company 29th Annual Health Care Conference
Theravance Announces New Employment Inducement Award - Mar 2 2009 6:50PM
Theravance Receives Complete Response Letter on the Telavancin New Drug Application for the Treatment of cSSSI
Zacks Analyst Blog Highlights: Vivo, Telemig, NovaMed, Inc., General Mills and Theravance
Theravance Reports Fourth Quarter and Full Year 2008 Results
GSK and Theravance announce positive phase 2b results for once-daily fluticasone furoate in the treatment of asthma
Theravance Announces New Employment Inducement Awards - Feb 2 2009 9:09PM
Theravance to Report Fourth Quarter and Full Year 2008 Financial Results on February 12, 2009
Theravance Submits U.S. NDA for Telavancin for the Treatment of Hospital-Acquired Pneumonia
Theravance Announces New Employment Inducement Award - Jan 5 2009 7:17PM
GSK and Theravance Announce Positive Phase 2b Results for LABA '444 in the Treatment of COPD in the Horizon Development Programme
GSK and Theravance Announce Positive Phase 2b Results for LABA, '444 in the Horizon Asthma Development Programme
Theravance Announces New Employment Inducement Awards - Dec 1 2008 6:49PM
Theravance Reports Favorable Outcome of FDA Advisory Committee Meeting on Telavancin for the Treatment of Complicated Skin and Skin Structure Infections
Trading in Theravance Common Stock Halted
Theravance Announces Posting of Briefing Documents for FDA Anti-Infective Drugs Advisory Committee Meeting on Telavancin
Theravance to Present at the Credit Suisse Phoenix Healthcare Conference
Theravance Announces New Employment Inducement Awards - Market Wire
Theravance Reports Third Quarter 2008 Financial Results
Telavancin Data to Be Presented at Upcoming Scientific Conferences
Theravance Announces FDA Advisory Committee to Review Telavancin for the Treatment of Complicated Skin and Skin Structure Infections
Theravance to Report Third Quarter 2008 Financial Results on October 23, 2008
Theravance Announces New Employment Inducement Award
Theravance to Present at the Thomas Weisel Partners Healthcare Conference
Theravance Reports Second Quarter 2008 Financial Results
Theravance Announces Regulatory Update on Telavancin for the Treatment of Complicated Skin and Skin Structure Infections
Theravance Announces Clinical Results in the LAMA Respiratory Program for the Treatment of COPD
Theravance Announces Positive Phase 2 Clinical Results in the MABA Respiratory Program for the Treatment of COPD
Theravance to Report Second Quarter 2008 Financial Results on July 24, 2008
Theravance to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference - May 28 2008 4:18PM
Theravance to Present at the Morgan Stanley Global Healthcare Unplugged Conference
Theravance Reports First Quarter 2008 Financial Results
Theravance to Webcast 2008 Annual Meeting of Stockholders on April 22, 2008
Theravance to Report First Quarter 2008 Financial Results on April 21, 2008